Glutaraldehyde-Fixed Kangaroo Aortic Wall Tissue: Histology, Crosslink Stability and Calcification Potential

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 66, Issue 1, 2003, Pages 356-363

  Neethling, William M L ^a,b   Hodge, A J ^b   Glancy, R ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

Author keywords

Aortic wall; Calcification; Kangaroo; Porcine; Subcutaneous implants

Indexed keywords

CALCIFICATION (BIOCHEMISTRY); COLLAGEN; CROSSLINKING; HEART VALVE PROSTHESES; TISSUE;

ANTIGENICITY;

HISTOLOGY;

COLLAGEN; CALCIUM; CROSS LINKING REAGENT; ELASTIN; FIXATIVE; GLUTARALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENICITY; AORTA VALVE; AORTA WALL; ARTICLE; BIOPROSTHESIS; CALCIFICATION; CONTROLLED STUDY; CROSS LINKING; HEART VALVE PROSTHESIS; HISTOLOGY; KANGAROO; MORPHOLOGY; NONHUMAN; PROTEIN STABILITY; RAT; RAT STRAIN; SWINE; TISSUE FIXATION; ANIMAL; CALCINOSIS; COMPARATIVE STUDY; MALE; MARSUPIAL; MATERIALS TESTING; WISTAR RAT;

ANIMALS; BIOPROSTHESIS; CALCINOSIS; CALCIUM; COLLAGEN; CROSS-LINKING REAGENTS; ELASTIN; FIXATIVES; GLUTARAL; HEART VALVE PROSTHESIS; MACROPODIDAE; MALE; MATERIALS TESTING; RATS; RATS, WISTAR; SUS SCROFA; TISSUE FIXATION;

EID: 0347384139     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.b.10015     Document Type: Article

References (42)

1. Broom ND, Thompson FJ. Influence of fixation conditions on the performance of glutaraldehyde-treated aortic valves: Towards a more scientific basis. Thorax 1979;34:166-176.
2. Jayakrishnan A, Jameela SR. Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices. Biomaterials 1996; 17:471-484.
3. Huang-Lee LLH, Cheung DT, Nimni ME. Biochemical changes and cytotoxicity associated with degradation of polymeric glutaraldehyde derived cross-links. J Biomed Mater Res 1990;24: 1185-1201.
4. Golomb G, Schoen FJ, Smith MS, Lindin J, Dixon M, Levy RJ. The role of glutaraldehyde-induced crosslinks in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol 1987;127:122-130.
5. Biedrzycki LM, Lerner E, Levy RJ, Schoen FJ. Differential calcification of cusps and aortic wall of failed porcine bioprosthetic valves. J Biomed Mater Res 1997;34:411-415.
6. Levy RJ, Schoen FJ, Lund SA, Smith MS. Prevention of leaflet calcification of bioprosthetic heart valves with diphosphonate injection therapy. J Thorac Cardiovasc Surg 1987;94:551-557.
7. 3 preincubations. J Biomed Mater Res 1991;25:905-935.
8. Gott JP et al. Calcification of porcine valves: Asuccessful new method of anti-mineralization. Ann Thorac Surg 1992;53:207-216.
9. Schoen FJ, Levy RJ. Tissue heart valves: Current challenges and future research perspectives. J Biomed Mater Res 1999;47: 439-465.
10. Melina G, Rubens MB, Birks EJ, Bizzarri F, Khaghani A, Yacoub MH. A quantitative study of calcium deposition in the aortic wall following Medtronic Freestyle compared with homograft aortic root replacement. A prospective randomized trial. J Heart Valve Dis 2000;9:97-103.
11. Neethling WML, Papadimitriou JM, Swarts E, Hodge AJ. Kangaroo versus porcine aortic valve tissue-Valvegeometry, morphology, tensile strength and calcification potential. J Cardiovasc Surg 2000;41:341-347.
12. Neethling WM, Van Riet S, Van den Heever JJ, Hough J, Hodge AJ. Evaluation of kangaroo aortic valved conduits in a juvenile sheep model-preliminary findings. J Cardiac Surg 2001;16:392-399.
13. Hardy PM, Nicholls AC, Rydon HN. The nature of the crosslinking of proteins by glutaraldehyde. Part I. Interaction of glutaraldehyde with the amino-groups of 6-aminohexanoic acid and of alpha-N-acetyl-lysine. J Chem Soc [Perkin 1] 1976;9: 958-962.
14. Zilla P, Zhang Y, Human P, Koen W, Von Oppell U. Improved ultrastructural preservation of bioprosthetic tissue. J Heart Valve Dis 2000;9:97-103.
15. Woodroof EA. Use of glutaraldehyde and formaldehyde to process tissue heart valves. J Bioeng 1978;2:1-9.
16. Wolinsky H. Response of the rat aortic wall to hypertension: Importance of comparing absolute amounts of wall components. Atherosclerosis 1970;11:251-255.
17. Woessner JF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 1961;93:440-447.
18. Keeley FW, Morin JD, Vesely S. Characterization of collagen from normal human sclera. Exp Eye Res 1984;39:533-542.
19. Richards FM, Knowles JR. Glutaraldehyde as a protein crosslinking reagent. J Mol Biol 1968;37:231-233.
20. Lee CH, Vyavahare N, Zand R, Kruth H, Schoen FJ, Bianco R, Levy RJ. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: Biochemical and biophysical mechanisms. J Biomed Mater Res 1998;42:30-37.
21. Carpentier A, Lemaigre G, Robert L, Carpentier S, Dubost C. Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg 1969;58:467-483.
22. Cheung DT, Nimni ME. Mechanism of crosslinking of proteins by glutaraldehyde III: Reaction with collagen in tissues. Connect Tissue Res 1985;13:109-115.
23. Hughes H, Collwell A, McClurg WM, Lawford PV. Explanted bio-prosthetic heart valves: Crosslinks and calcium analysis. J Pathol 1997;181:31A.
24. Milano A et al. Calcific degeneration as the main cause of porcine bioprosthetic valve failure. Am J Cardiol 1984;53: 1066-1070.
25. Schoen FJ, Harasaki H, Kim KM, Anderson HC, Levy RJ. Biomaterial-associated calcification. Pathology, mechanism, and strategies for prevention. J Biomater Res 1988;22:11-36.
26. Fiddler GI, Gerlis LM, Walker DR, Scott O, Williams GJ. Calcification of glutaraldehyde-preserved porcine and bovine xenograft valves in young children. Ann Thorac Surg 1983;35: 257-262.
27. Simionescu A, Simionescu D, Deac R. Biochemical pathways of tissue degeneration in bioprosthetic cardiac valves. The role of matrix metalloproteinases. ASAIO J 1996;42:561-567.
28. Liao K, Seifter E, Hoffman D, Yellin EL, Frater RWM. Bovine pericardium versus porcine aortic valve: Comparison of tissue biological properties as prosthetic valves. Artif Organs 1992; 16:361-365.
29. Neethling WML, Van den Heever JJ, Meyer JM, Barnard HC. Processing factors as determinants of tissue valve calcification. J Cardiovasc Surg 1992;3:285-291.
30. Vyavahare N, Hirsch D, Lerner E, Baskin JZ, Schoen FJ, Bianco R, Kruth HS, Zand R, Levy RJ. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation 1997;95:479-488.
31. Chen W, Schoen FJ, Levy RJ. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation 1994;90:323-329.
32. Van Nooten G, Ozaki S, Herijgers P, Van Belleghem Y, Flameng W. Deformation of the stentless porcine valve scaffold enhances accelerated leaflet fibrosis and calcification in juvenile sheep. Semin Thorac Cardiovasc Surg 1999;11(4 Suppl 1):163-170.
33. Bianco RW, Phillips R, Mrachek J, Witson J. Feasibility evaluation of a new pericardial bioprosthesis with dye mediated photo-oxidized bovine pericardial tissue. J Heart Valve Dis 1996;5:317-322.
34. Gabbay S, Welch H. Reducing the variability in durability of heart valve bioprostheses. Trans Am Soc Artif Intern Organs 1988;34:1022-1026.
35. Heidemann E. Fundamentals of leather manufacturing (1st ed.). Munchen, Germany: Hanser; 1993.
36. Tu R, Shen SH, Lin D, Hata C, Thyagarajan K, Noishiki Y, Quijano RC. Fixation of bioprosthetic tissues with monofunctional and multifunctional polyepoxy compounds. J Biomed Mater Res 1994;28:677-684.
37. Samouillan V, Dandurand-Lods J, Lamure A, Maurel E, Lacabanne C, Gerosa G, Venturini A, Casarotto D, Gherardini L, Spina M. Thermal analysis characterization of aortic tissues for cardiac valve bioprostheses. J Biomed Mater Res 1999;46:531-538.
38. Liao K, Seifter E, Hoffman D, Yellin EL, Frater RW. Improved postfixation treatment of glutaraldehyde fixed porcine aortic valves by monosodium glutamate. Artif Organs 1992;16:267-272.
39. Singla A, Lee CH. Effect of elastin on the calcification rate of collagen-elastin matrix systems. J Biomed Mater Res 2002;60: 368-374.
40. Zilla P, Bezuidenhout D, Weissenstein C, van der Walt A, Human P. Diamine extension of glutaraldehyde crosslinks mitigates bioprosthetic aortic wall calcification in the sheep model. J Biomed Mater Res 2001;56:56-64.
41. Nimni ME, Myers D, Ertl D, Han B. Factors which affect the calcification of tissue derived bioprostheses. J Biomed Mater Res 1997;35:531-537.
42. Weissenstein C, Human P, Bezuidenhout D, Zilla P. Glutaraldehyde detoxification in addition to enhanced amine crosslinking dramatically reduces bioprosthetic tissue calcification in the rat model. J Heart Valve Dis 2000;9:230-240.